STOCK TITAN

Keurig Dr Pepper completes stock offering at $34.50

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Keurig Dr Pepper Inc. (KDP) completed a public offering of 57,971,015 common shares at $34.50 per share on November 16, 2026. The underwriters, Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC, exercised their option in full, adding 8,695,652 shares. KDP received approximately $2.25 billion in net proceeds after the underwriting discount; that figure does not deduct other offering fees and expenses.

KDP intends to use the net proceeds to repay or repurchase outstanding debt, which may include borrowings under its Delayed Draw Term Loan Agreement, commercial paper notes and senior unsecured notes. KDP also said it intends to repay or repurchase approximately $2.0 billion aggregate principal amount of debt. The company said the deleveraging is intended to precede its separation into Beverage Co. and Global Coffee Co., targeted for early 2027, and is expected to strengthen both companies’ investment-grade ratings profiles.

Filing Explained

KDP completed the offering on November 16, selling 57,971,015 common shares and 8,695,652 additional shares under the option; those additional shares increase the share count and reduce existing holders’ percentage ownership, absent offsetting changes.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Shares sold 57,971,015 shares Public offering completed November 16, 2026
Offering price $34.50 per share Public offering
Additional shares sold 8,695,652 shares Underwriters exercised their option in full
Net proceeds Approximately $2.25 billion After the underwriting discount; before other offering fees and expenses
Debt principal to repay or repurchase Approximately $2.0 billion aggregate principal amount KDP stated its intended use of proceeds
underwriting discount financial
"after deducting the underwriting discount"
The underwriting discount is the fee that investment banks or broker-dealers keep when they buy securities from an issuer and resell them to the public; it’s the difference between the price paid to the company and the public offering price, shown per share or as a percentage. It matters to investors because it reduces the cash the company actually raises and is a cost built into the deal—like a sales commission—so a larger discount can mean higher issuance costs, tighter returns for new investors, and a signal about how much effort underwriters must expend to sell the offering.
aggregate principal amount financial
"approximately $2.0 billion aggregate principal amount"
The aggregate principal amount is the total amount of money borrowed through a bond or loan that the borrower promises to repay. It’s like the original price tag on a loan or bond, showing how much money is involved in the deal. This number matters because it indicates the size of the debt and helps investors understand the scale of the borrowing.
Delayed Draw Term Loan Agreement financial
"borrowings under its Delayed Draw Term Loan Agreement"
commercial paper notes financial
"commercial paper notes and senior unsecured notes"
Short-term IOUs issued by companies to raise quick cash, typically for working capital or short-term obligations; they mature in days to months rather than years. Think of them like a company’s short-term promissory note to investors or money-market funds: they matter because their availability, interest rate and perceived safety signal a firm’s liquidity and credit health, and they offer investors a low-risk, short-duration place to park cash but carry some default risk.
automatic shelf registration statement regulatory
"an automatic shelf registration statement on Form S-3"
An automatic shelf registration statement is a pre-approved filing that companies submit to securities regulators, allowing them to sell new shares or bonds quickly and efficiently when needed. It acts like a standing permit, enabling the company to raise money without going through a lengthy approval process each time, which can be helpful for responding promptly to market opportunities or needs. For investors, it provides transparency about the company's ability to raise funds and signals planning flexibility.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did KDP sell in its offering, and at what price?

KDP sold 57,971,015 shares at $34.50 per share, and the underwriters exercised in full their option to purchase an additional 8,695,652 shares.

How much net proceeds did KDP receive, and how does it plan to use them?

KDP received approximately $2.25 billion in net proceeds after the underwriting discount, without deducting other offering fees and expenses. It intends to use the proceeds to repay or repurchase outstanding debt, including potentially borrowings under its Delayed Draw Term Loan Agreement, commercial paper notes and senior unsecured notes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001418135 0001418135 2026-11-12 2026-11-12
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 12, 2026

 

 

 

LOGO

Keurig Dr Pepper Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-33829   98-0517725

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

6425 Hall of Fame Lane, Frisco, Texas 75034

(Address of principal executive offices) (Zip Code)

(800) 527-7096

(Registrant’s telephone number, including area code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common Stock   KDP   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 8.01. Other Events.

On November 12, 2026, Keurig Dr Pepper Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC (the “Underwriters”), pursuant to which the Company agreed to sell 57,971,015 shares of the Company’s common stock, par value $0.01 per share (“Common Stock”), at a public offering price of $34.50 per share (the “Offering”). In connection with the Offering, the Company granted the Underwriters an option to purchase up to an additional 8,695,652 shares of Common Stock.

The Underwriting Agreement includes customary representations, warranties and covenants by the Company. It also provides that the Company will indemnify the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The foregoing description of the Underwriting Agreement is not complete and is qualified in its entirety by reference to the complete text of the Underwriting Agreement, a copy of which is attached as Exhibit 1.1 and incorporated herein by reference.

On November 16, 2026, the Company completed the Offering, including 8,695,652 shares of Common Stock sold pursuant to the Underwriters’ exercise in full of their option to purchase additional shares. The Company received approximately $2.25 billion of net proceeds from the Offering, after deducting the underwriting discount (without deducting other offering fees and expenses). The Company intends to use the net proceeds to repay or repurchase its outstanding debt, which may include borrowings under its Delayed Draw Term Loan Agreement, commercial paper notes and senior unsecured notes.

The Offering was made pursuant to the Company’s registration statement on Form S-3ASR (File No. 333-289652) (the “Registration Statement”), as supplemented by a preliminary prospectus supplement, filed with the Securities and Exchange Commission (the “SEC”) on November 12, 2026, and a final prospectus supplement, dated November 12, 2026, filed with the SEC on November 13, 2026 pursuant to Rule 424(b) under the Securities Act. In connection with the Offering, the legal opinion as to the legality of the Common Stock sold in the Offering is being filed as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated herein and into the Registration Statement by reference.

On November 12, 2026, the Company issued press releases announcing the launch and the pricing of the Offering. Copies of the press releases are filed as Exhibits 99.1 and 99.2 hereto, respectively, and are incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

 

(d)

Exhibits.

 

Exhibit
No.
   Document Description
1.1    Underwriting Agreement, dated November 12, 2026, by and among Keurig Dr Pepper Inc., Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC.
5.1    Opinion of Paul, Weiss, Rifkind, Wharton & Garrison LLP.
23.1    Consent of Paul, Weiss, Rifkind, Wharton & Garrison LLP (included in Exhibit 5.1).
99.1    Press release issued by Keurig Dr Pepper Inc., dated November 12, 2026, announcing the launch of the offering.
99.2    Press release issued by Keurig Dr Pepper Inc., dated November 12, 2026, announcing the pricing of the offering.
104    Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

KEURIG DR PEPPER INC.
By:  

/s/ Anthony Shoemaker

  Name:   Anthony Shoemaker
  Title:   Chief Legal Officer, General Counsel and Secretary

Date: November 16, 2026

Exhibit 99.1

Keurig Dr Pepper Announces Proposed Public Offering of Common Stock

FRISCO, Texas and BURLINGTON, Mass. – Nov. 12, 2026 – Keurig Dr Pepper Inc. (NASDAQ: KDP) (“KDP” or the “Company”) today announced that it has commenced an underwritten public offering of $2.0 billion of shares of its common stock, par value $0.01 per share (the “Offering”). KDP’s common stock is listed on the Nasdaq Global Select Market under the symbol “KDP.”

KDP intends to grant the underwriters of the Offering a 30-day option to purchase up to an additional $300 million of shares of common stock, at the same price per share as the other shares of common stock purchased by the underwriters in the Offering. The Offering is subject to market and other customary conditions.

Consistent with its stated capital allocation strategy, KDP intends to use the net proceeds from the Offering to accelerate deleveraging to optimize its balance sheet ahead of the previously announced separation into two independent, publicly traded companies, Beverage Co. and Global Coffee Co., which is targeted to occur in early 2027. This deleveraging is expected to strengthen the investment grade ratings profile of both Beverage Co. and Global Coffee Co. and provide each company with additional financial capacity to invest and execute on their respective strategic priorities. KDP intends to use the net proceeds from the Offering to repay or repurchase approximately $2.0 billion aggregate principal amount of its outstanding debt, which may include borrowings under its delayed draw term loan, commercial paper notes and senior unsecured notes.

Goldman Sachs & Co. LLC and Morgan Stanley are acting as joint book-running managers for the Offering.

The Offering will be made only by means of an effective registration statement and a prospectus. The Company has previously filed with the U.S. Securities and Exchange Commission (the “SEC”) an automatic shelf registration statement (including a prospectus) on Form S-3 (File No. 333-289652) dated August 15, 2025, which became effective upon filing. This Offering is being made solely by means of a prospectus supplement and accompanying prospectus. A preliminary prospectus supplement and accompanying prospectus relating to and describing the terms of the Offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. When available, copies of the preliminary prospectus supplement and the accompanying base prospectus related to the Offering may be obtained from Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at 1-866-471-2526 or by email at prospectus-ny@ny.email.gs.com, or from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.


Investor Contact

Investor Relations

Keurig Dr Pepper

T: 888-340-5287 / IR@kdrp.com

Media Contact

Katie Gilroy

Keurig Dr Pepper

T: 781-418-3345 / katie.gilroy@kdrp.com

About Keurig Dr Pepper

Keurig Dr Pepper (Nasdaq: KDP) is a leading beverage company with more than 150 owned, licensed and partner brands that meet a wide range of needs and occasions. Our North American refreshment beverage business holds leadership positions across carbonated soft drinks, water, juice and mixers with a portfolio of iconic brands such as Dr Pepper®, Canada Dry®, Mott’s®, A&W®, Peñafiel®, GHOST®, 7UP®, Snapple®, Clamato® and Core Hydration®. Our global coffee business spans more than 100 markets and includes the leading Keurig® single-serve brewing system in the U.S. and Canada, along with powerhouse brands such as Peet’s, L’OR and Jacobs, and other regional coffee leaders. Our more than 50,000 employees aim to enhance the experience of every beverage and coffee occasion while making a positive impact for people, communities and the planet.

FORWARD-LOOKING STATEMENTS

Certain statements contained herein are “forward-looking statements” within the meaning of applicable securities laws and regulations, including statements regarding the completion, timing, size and terms of the Offering and the anticipated use of proceeds therefrom. These forward-looking statements can generally be identified by the use of words such as “outlook,” “guidance,” “anticipate,” “expect,” “believe,” “could,” “estimate,” “feel,” “forecast,” “intend,” “may,” “plan,” “potential,” “project,” “should,” “target,” “will,” “would,” and similar words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. These statements are based on the current expectations of our management, are not predictions of actual performance, and actual results may differ materially.

Forward-looking statements are subject to a number of risks and uncertainties, including the factors disclosed in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, the prospectus supplement and subsequent filings with the SEC. We are under no obligation to update, modify or withdraw any forward-looking statements, except as required by applicable law.

Exhibit 99.2

Keurig Dr Pepper Announces Pricing of Public Offering of Common Stock

FRISCO, Texas and BURLINGTON, Mass. – Nov. 12, 2026 – Keurig Dr Pepper Inc. (NASDAQ: KDP) (“KDP” or the “Company”) today announced the pricing of its previously announced underwritten public offering of 57,971,015 shares of its common stock, par value $0.01 per share (the “Offering”), at a price to the public of $34.50 per share. KDP’s common stock is listed on the Nasdaq Global Select Market under the symbol “KDP.”

KDP has granted the underwriters of the Offering a 30-day option to purchase up to an additional 8,695,652 shares of common stock, at the same price per share as the other shares of common stock purchased by the underwriters in the Offering. The Offering is expected to close on November 16, 2026, subject to customary closing conditions.

Consistent with its stated capital allocation strategy, KDP intends to use the net proceeds from the Offering to accelerate deleveraging to optimize its balance sheet ahead of the previously announced separation into two independent, publicly traded companies, Beverage Co. and Global Coffee Co., which is targeted to occur in early 2027. This deleveraging is expected to strengthen the investment grade ratings profile of both Beverage Co. and Global Coffee Co. and provide each company with additional financial capacity to invest and execute on their respective strategic priorities. KDP intends to use the net proceeds from the Offering to repay or repurchase approximately $2.0 billion aggregate principal amount of its outstanding debt, which may include borrowings under its delayed draw term loan, commercial paper notes and senior unsecured notes. To the extent the underwriters exercise their option to purchase additional shares, we intend to use any additional net proceeds to further repay or repurchase outstanding debt.

Goldman Sachs & Co. LLC and Morgan Stanley are acting as joint book-running managers for the Offering.

The Offering will be made only by means of an effective registration statement and a prospectus. The Company has previously filed with the U.S. Securities and Exchange Commission (the “SEC”) an automatic shelf registration statement (including a prospectus) on Form S-3 (File No. 333-289652) dated August 15, 2025, which became effective upon filing. This Offering is being made solely by means of a prospectus supplement and accompanying prospectus. A final prospectus supplement and accompanying prospectus relating to and describing the terms of the Offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. When available, copies of the final prospectus supplement and the accompanying base prospectus related to the Offering may be obtained from Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at 1-866-471-2526 or by email at prospectus-ny@ny.email.gs.com, or from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.


Investor Contact

Investor Relations

Keurig Dr Pepper

T: 888-340-5287 / IR@kdrp.com

Media Contact

Katie Gilroy

Keurig Dr Pepper

T: 781-418-3345 / katie.gilroy@kdrp.com

About Keurig Dr Pepper

Keurig Dr Pepper (Nasdaq: KDP) is a leading beverage company with more than 150 owned, licensed and partner brands that meet a wide range of needs and occasions. Our North American refreshment beverage business holds leadership positions across carbonated soft drinks, water, juice and mixers with a portfolio of iconic brands such as Dr Pepper®, Canada Dry®, Mott’s®, A&W®, Peñafiel®, GHOST®, 7UP®, Snapple®, Clamato® and Core Hydration®. Our global coffee business spans more than 100 markets and includes the leading Keurig® single-serve brewing system in the U.S. and Canada, along with powerhouse brands such as Peet’s, L’OR and Jacobs, and other regional coffee leaders. Our more than 50,000 employees aim to enhance the experience of every beverage and coffee occasion while making a positive impact for people, communities and the planet.

FORWARD-LOOKING STATEMENTS

Certain statements contained herein are “forward-looking statements” within the meaning of applicable securities laws and regulations, including statements regarding the completion and timing of the Offering and the anticipated use of proceeds therefrom. These forward-looking statements can generally be identified by the use of words such as “outlook,” “guidance,” “anticipate,” “expect,” “believe,” “could,” “estimate,” “feel,” “forecast,” “intend,” “may,” “plan,” “potential,” “project,” “should,” “target,” “will,” “would,” and similar words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. These statements are based on the current expectations of our management, are not predictions of actual performance, and actual results may differ materially.

Forward-looking statements are subject to a number of risks and uncertainties, including the factors disclosed in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, the prospectus supplement and subsequent filings with the SEC. We are under no obligation to update, modify or withdraw any forward-looking statements, except as required by applicable law.

Filing Exhibits & Attachments

7 documents

Keep reading